Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Askbio Inc

Clinical trials sponsored by Askbio Inc, explained in plain language.

Now part of Bayer AG BAYN XETRA

A gene therapy company, subsidiary of Bayer.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 2 Completed 3

Brain infusion upgrade: could a new method make Parkinson's treatment easier?

Disease control Not yet recruiting

This study tests a new, faster method to deliver the drug AB-1005 into the brain of people with advanced Parkinson's disease. The goal is to see if the new approach can consistently reach the target area while being safer and quicker. 18 participants will be enrolled to assess th…

Phase: PHASE2 • Sponsor: AskBio Inc • Aim: Disease control

Last updated Jul 29, 2026 00:00 UTC